Decreasing mean transistor size since 2000. by David Burg (8209752)

Comparison of ∑PCDD/F, PCDD/F TEQ, ∑PCB, PCB TEQ and ∑TEQ concentrations in eggs analyzed in this study and other relevant studies (pg/g ww except for ∑PCB ng/g ww, geometric mean... by Matti Viluksela (321291)

Fx controls the TNF-enhanced Ser/5-HT-promoted <i>Trypanosoma cruzi</i> uptake by U-87 MG cells and neuromediators availability. by Glaucia Vilar-Pereira (686134)

Effects of H5 (20 and 40 mg/kg, p.o.), and diazepam (2.5 mg/kg, i.p.) in the Rota-rod test in mice. by Maria Alice Miranda Bezerra Medeiros (11752002)

Fig 5 - by Dalia Zaafar (6693017)

Immunohistochemical analysis of p-Akt expression in various experimental groups showing negative expression in control group, marked increased expression along the extended fibrous... by Rehab F. Abdel-Rahman (11886404)

Adverse events in low-dose naltrexone arm. by Judith I. Tsui (5983160)

Subjects:

CONSORT flow diagram. by Judith I. Tsui (5983160)

Subjects:

Adverse events in placebo arm. by Judith I. Tsui (5983160)

Subjects:

Medication tolerability, discontinuations, adherence over the 8-week study period. by Judith I. Tsui (5983160)

Subjects:

Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

Subjects:

Medication satisfaction over 8-week study medication period. by Judith I. Tsui (5983160)

Subjects:

Main results: Changes in primary and secondary outcomes from baseline to 8 weeks in the PETER PAIN trial. by Judith I. Tsui (5983160)

Subjects:

Baseline characteristics of PETER PAIN study participants: People with HIV, chronic pain, and heavy alcohol use (n = 45). by Judith I. Tsui (5983160)

Subjects:

Baseline characteristics of study subjects (n = 136). by Herindita Puspitaningtyas (11618232)

Subjects:

Minimal data set. by Herindita Puspitaningtyas (11618232)

Subjects:

Correlation between baseline vitamin D level with socio-demographic factors and clinicopathology characteristics (n = 136). by Herindita Puspitaningtyas (11618232)

Subjects:

Vitamin D concentration changes between baseline and post-chemotherapy in breast cancer patients (n = 136). by Herindita Puspitaningtyas (11618232)

Subjects:

Flowchart of subjects’ inclusion process. by Herindita Puspitaningtyas (11618232)

Subjects:

CXCL10 production is enhanced in the setting of HIV and HBV co-infection in vitro and decreased with the addition of antiretroviral agents efavirenz or raltegravir. by Kasha P. Singh (9354307)